Thailand IVF 2025 Latest Updates & Clinical Guide

AI Summary

Current Policies and Technology Status of Thailand IVF

As of 2025, Thailand's regulatory framework for assisted reproduction remains stable. IVF and PGT are legally practiced in Thailand, under the supervision of the Medical Services Department of the Thai Ministry of Health. Key policy points are as follows:

• IVF and PGT Legal: Thailand permits Preimplantation Genetic Testing for Aneuploidy (PGT-A), Structural Rearrangements (PGT-SR), and Monogenic Disorders (PGT-M).
• Commercial Surrogacy Banned: The 2015 "Protection of Children Born from Assisted Reproductive Technologies Act" explicitly bans commercial surrogacy. Only related surrogacy is allowed, subject to ethics committee approval.
• Restricted Egg/Embryo Donation: Anonymous donation is allowed, but recipients cannot simultaneously transfer their own embryos after receiving donor-egg embryos.
• International Patient Policy: Thailand does not restrict international patients from receiving assisted reproductive treatment, but they must hold a valid visa (medical or tourist visa) and register at a licensed fertility center.

Compared to China, Thailand has slightly broader indications for PGT, and some centers have their own embryology genetics labs, shortening testing turnaround times. However, not all patients are suitable for cross-border treatment. A comprehensive assessment including ovarian reserve, age, and underlying diseases is necessary.

Impact of Age and Ovarian Reserve on Thailand IVF

Age is one of the most critical variables affecting Thailand IVF success rates. Examination priorities, medication protocols, expected oocyte yield, and transfer strategies vary significantly across age groups.

Clinical data shows that the embryo euploidy rate for women over 40 is approximately 20%–30%. PGT-A screening can significantly improve implantation rates per transfer, but requires high laboratory standards for embryo biopsy. Some Thai centers use time-lapse imaging combined with AI embryo scoring systems to select embryos with the best developmental potential.

Complete Thailand IVF Process and Key Milestones

A standard Thailand IVF cycle includes the following steps, spanning approximately 45–60 days, typically requiring two trips to Thailand:

Phase 1: Domestic Preparation and Evaluation (1–3 months before travel)

• Basic Fertility Assessment: Female: AMH, FSH, LH, Estradiol, Antral Follicle Count; Male: Semen analysis (including morphology and DNA fragmentation index).
• Chromosome Analysis and Genetic Counseling: Karyotype for both partners; carrier screening if family history of genetic disorders.
• Infectious Disease Screening: Hepatitis B, Hepatitis C, HIV, Syphilis, Cytomegalovirus; some Thai centers require reports within 3 months.
• Uterine Cavity Evaluation: Hysteroscopy or hysterosalpingography recommended to rule out polyps, adhesions, chronic endometritis, etc.
• Document Preparation: Passport (validity ≥ 18 months), notarized and translated marriage certificate, visa (medical or tourist).

Phase 2: First Trip to Thailand (approx. 12–16 days)

• Registration and Doctor Consultation: Bring all original test reports and translations, register at the fertility center, confirm stimulation protocol.
• Ovarian Stimulation: Approximately 10–12 days, monitoring follicle growth and hormone levels every 2–3 days, adjusting medication dosage.
• Egg Retrieval: Transvaginal ultrasound-guided follicle aspiration under intravenous anesthesia, lasting about 15–20 minutes.
• Embryo Culture and PGT: Cleavage-stage biopsy on day 3 or blastocyst biopsy on day 5–6; PGT testing cycle takes about 7–10 days.

Phase 3: Second Trip for Transfer (approx. 5–7 days)

• Endometrial Preparation: Natural or artificial cycle to prepare the endometrium, target thickness 7–14mm with a trilaminar pattern.
• Frozen Embryo Transfer: Transfer 1–2 PGT-screened blastocysts at the time determined by the doctor.
• Luteal Phase Support: Progesterone medication after transfer, continued until the pregnancy test day.
• Pregnancy Test: Blood test for β-hCG on day 9–12 after transfer to confirm pregnancy.

Timeline: How Far in Advance to Prepare for Overseas IVF

From the decision to undergo Thailand IVF to completing the transfer, the overall timeline is as follows:

• 3–6 months before: Complete all preliminary tests (AMH, FSH, chromosome, infectious disease, hysteroscopy, semen analysis), address potential issues affecting pregnancy (e.g., thyroid dysfunction, vitamin D deficiency, endometrial polyps).
• 1–2 months before: Choose a fertility center, schedule a doctor appointment, renew passport if validity < 18 months, notarize marriage certificate, apply for visa.
• First trip to Thailand: 12–16 days (stimulation + egg retrieval).
• Waiting for PGT results: 7–14 days (can wait in home country).
• Second trip for transfer: 5–7 days.

Total span is approximately 3–4 months, but if multiple stimulation cycles are needed to accumulate embryos, the time extends to 6–9 months.

Cost Breakdown and Influencing Factors

The total cost of Thailand IVF varies significantly depending on the fertility center, medication protocol, whether PGT is performed, and the need for translation services. The following are typical cost ranges for 2025:

The total cost for a single complete cycle (including PGT) is approximately 120,000–220,000 RMB. If embryo accumulation is needed (2–3 stimulation cycles), the total cost may rise to 300,000–400,000 RMB. Cost transparency is an important factor when choosing a fertility center; it is advisable to obtain a detailed fee schedule before signing a contract.

Interpretation and Clinical Significance of Key Tests

The following indicators are central to the preliminary evaluation for Thailand IVF, directly influencing protocol selection and prognosis:

• AMH (Anti-Müllerian Hormone): Reflects ovarian reserve. AMH ≥ 1.0 ng/mL suggests a favorable expected oocyte yield; 0.5–1.0 ng/mL requires protocol adjustment; < 0.5 ng/mL may necessitate cumulative cycles or egg donation.
• FSH (Follicle-Stimulating Hormone): Basal FSH (day 2–3 of cycle) < 8 IU/L is good; 8–13 IU/L indicates diminished reserve; > 13 IU/L warrants cautious assessment of ovarian response.
• LH (Luteinizing Hormone): Basal LH helps identify PCOS tendency (LH/FSH ratio > 2) or hypogonadotropic states.
• Antral Follicle Count (AFC): Total number of follicles 2–10mm in both ovaries. < 5 indicates severely diminished ovarian reserve.
• Semen Analysis: Concentration ≥ 15×10⁶/mL, progressive motility ≥ 32%, normal morphology ≥ 4%. DNA Fragmentation Index (DFI) < 15% is excellent; 15–30% requires management; > 30% significantly impacts blastocyst formation rate.

Most Easily Overlooked Details and Pitfall Reminders

In the actual process of cross-border medical treatment, the following details are often overlooked but can directly affect the smooth progress of the cycle:

• Passport Validity: Thailand requires a passport validity of at least 18 months (from the date of entry). Some centers have stricter requirements. If validity is insufficient, renew early, which takes 2–3 weeks.
• Test Report Validity: Infectious disease screening (within 3 months), semen analysis (within 6 months), AMH (within 1 year) must be valid. Chromosome tests are valid for life but require original reports.
• Marriage Certificate Notarization: Thai fertility centers require a notarized Chinese-English marriage certificate for registration. This is done at your local notary office and takes 5–10 business days.
• Visa Type: IVF treatment is permitted on a tourist visa, but each stay cannot exceed 60 days. For multiple entries, a medical visa (requiring a hospital letter) is recommended.
• Medication Carrying: Stimulation medications must be purchased in Thailand or brought with a prescription. Some medications (e.g., growth hormone) require prior declaration.
• Insurance Coverage: Most travel insurance does not cover complications of assisted reproduction (e.g., OHSS, post-retrieval bleeding). Consider purchasing insurance specifically covering assisted reproduction risks.

Frequently Asked Questions and Objective Answers

The following are high-frequency questions distilled from real consultations, with answers based on the 2025 consensus in the Thai assisted reproduction industry:

• Can I still do Thailand IVF with low AMH? Yes. AMH ≥ 0.5 ng/mL still offers a chance to retrieve eggs, but you should accept the possibility of a low oocyte yield (usually 1–4). Be prepared for embryo accumulation. AMH < 0.5 ng/mL can be attempted, but the egg donation option should also be evaluated.
• What additional preparations are needed for advanced age (≥ 40) going to Thailand for IVF? In addition to routine tests, it is recommended to add telomere length testing, mitochondrial DNA copy number assessment, and endometrial receptivity analysis (ERA) to optimize the transfer window.
• Is pre-IVF conditioning necessary for Thailand IVF? Yes. It is recommended to start 3 months in advance with Coenzyme Q10 (200–400 mg/day), Vitamin D3 (2000–5000 IU/day), and Melatonin (2–5 mg/day at bedtime) to improve egg quality. For men, Zinc, Selenium, and L-carnitine are recommended. Also, maintain a BMI between 18.5 and 24, and quit smoking and alcohol.
• What documents are needed for Thailand IVF registration? Original ID cards, passports, marriage certificate with Chinese-English notarization, all original test reports with translations, infectious disease screening reports within 3 months, and chromosome reports.
• Does the male partner have to go to Thailand? The male partner must be present on the egg retrieval day to provide a semen sample. If he cannot travel, semen can be frozen in advance and shipped to the Thai center, but you must confirm the center accepts cross-border frozen semen transport.

Practitioner Observations: The Real Situation of Thailand IVF

Based on collaboration experience with multiple Thai fertility centers over the past two years, here are some noteworthy trends:

• Rising Demand for PGT: In 2024–2025, over 60% of patients chose PGT-A, especially those aged ≥ 35 and those with a history of miscarriage. PGT report times in Thai centers have shortened from 10–14 days to 7–9 days.
• Significant Lab Quality Differences: Blastocyst formation rates, euploidy rates, and survival rates after thawing vary significantly between centers. When choosing a center, look for embryology data (e.g., blastocyst formation rate ≥ 50%, survival rate after thawing ≥ 95%).
• Increased Demand for Full Cycle Management: Patients are no longer satisfied with a single cycle but require a complete closed-loop management including pre-cycle conditioning, stimulation, embryo selection, endometrial preparation, and post-transfer support. Some centers have launched a "remote initial consultation + domestic monitoring + Thailand operation" collaboration model.
• Risk Awareness Needs Strengthening: Some patients underestimate the risks of OHSS, multiple pregnancy, and embryo biopsy. Thailand regulations limit transferred embryos to 2, but the twin pregnancy rate remains relatively high.